HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Primary Vitreoretinal Lymphoma

Primary Vitreoretinal Lymphoma

Primary vitreoretinal lymphoma (PVRL) is a rare type of non-Hodgkin lymphoma that affects the eyes, specifically the retina and vitreous. It typically presents as blurred vision, floaters, or loss of vision in one or both eyes. PVRL is challenging to diagnose due to its similarity to other eye conditions. Recent advances in cancer research have highlighted the importance of early detection through improved imaging techniques and molecular analysis of vitreous samples. Treatment often involves a combination of chemotherapy, radiation therapy, and intravitreal injections. However, the prognosis remains guarded, with a high risk of recurrence and potential central nervous system involvement. Ongoing research aims to elucidate the underlying mechanisms of PVRL development and identify novel targeted therapies to improve patient outcomes.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp